190 related articles for article (PubMed ID: 10599051)
1. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
Campbell B; Chuhran CM; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.
Campbell B; Adams J; Shin YK; Lefer AM
J Mol Cell Cardiol; 1999 Feb; 31(2):467-76. PubMed ID: 10093058
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
Campbell B; Shin YK; Scalia R; Lefer AM
Cardiovasc Res; 1998 Aug; 39(2):393-400. PubMed ID: 9798524
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia--reperfusion injury.
Habazettl H; Hanusch P; Kupatt C
Z Kardiol; 2000; 89 Suppl 9():IX/92-5. PubMed ID: 11151804
[TBL] [Abstract][Full Text] [Related]
6. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
7. c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury.
Kupatt C; Habazettl H; Hanusch P; Wichels R; Hahnel D; Becker BF; Boekstegers P
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2226-32. PubMed ID: 11031208
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.
Young LH; Ikeda Y; Lefer AM
Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2489-95. PubMed ID: 11356603
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
[TBL] [Abstract][Full Text] [Related]
10. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.
Young LH; Ikeda Y; Scalia R; Lefer AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1453-9. PubMed ID: 11009429
[TBL] [Abstract][Full Text] [Related]
11. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins.
Lefer AM; Campbell B; Scalia R; Lefer DJ
Circulation; 1998 Sep; 98(13):1322-8. PubMed ID: 9751682
[TBL] [Abstract][Full Text] [Related]
12. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion.
Lefer AM; Campbell B; Shin YK
J Mol Cell Cardiol; 1998 Dec; 30(12):2561-6. PubMed ID: 9990528
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
[TBL] [Abstract][Full Text] [Related]
14. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT; Wang QD; Pernow J
Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
[TBL] [Abstract][Full Text] [Related]
15. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
[TBL] [Abstract][Full Text] [Related]
17. Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart.
Shin YK; Campbell B; Lefer AM
Methods Find Exp Clin Pharmacol; 1998; 20(6):463-71. PubMed ID: 9789870
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
Young LH; Ikeda Y; Lefer AM
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):107-14. PubMed ID: 11523308
[TBL] [Abstract][Full Text] [Related]
19. PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
Ikeda Y; Young LH; Scalia R; Ross CR; Lefer AM
Cardiovasc Res; 2001 Jan; 49(1):69-77. PubMed ID: 11121797
[TBL] [Abstract][Full Text] [Related]
20. Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion.
Bertuglia S; Giusti A
BMC Cardiovasc Disord; 2002 Jun; 2():10. PubMed ID: 12086588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
